{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:27:42Z","timestamp":1793874462247,"version":"4.6.1"},"reference-count":260,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T00:00:00Z","timestamp":1609286400000},"content-version":"vor","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000320","name":"Alzheimer's Society","doi-asserted-by":"crossref","award":["AS-PG-17b-004"],"award-info":[{"award-number":["AS-PG-17b-004"]}],"id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Alzheimer's Research UK","award":["ARUK-PG2015-11"],"award-info":[{"award-number":["ARUK-PG2015-11"]}],"id":[{"id":"https:\/\/ror.org\/02ymzm013","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Alzheimer's Research UK","award":["ARUK-NAS2016B-1"],"award-info":[{"award-number":["ARUK-NAS2016B-1"]}],"id":[{"id":"https:\/\/ror.org\/02ymzm013","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["A2016582S"],"award-info":[{"award-number":["A2016582S"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    COVID-19 is primarily a respiratory disease but up to two thirds of hospitalised patients show evidence of central nervous system (CNS) damage, predominantly ischaemic, in some cases haemorrhagic and occasionally encephalitic. It is unclear how much of the ischaemic damage is mediated by direct or inflammatory effects of virus on the CNS vasculature and how much is secondary to extracranial cardiorespiratory disease. Limited data suggest that the causative SARS-CoV-2 virus may enter the CNS via the nasal mucosa and olfactory fibres, or by haematogenous spread, and is capable of infecting endothelial cells, pericytes and probably neurons. Extracranially, SARS-CoV-2 targets endothelial cells and pericytes, causing endothelial cell dysfunction, vascular leakage and immune activation, sometimes leading to disseminated intravascular coagulation. It remains to be confirmed whether endothelial cells and pericytes in the cerebral vasculature are similarly targeted. Several aspects of COVID-19 are likely to impact on cognition. Cerebral white matter is particularly vulnerable to ischaemic damage in COVID-19 and is also critically important for cognitive function. There is accumulating evidence that cerebral hypoperfusion accelerates amyloid-\u03b2 (A\u03b2) accumulation and is linked to tau and TDP-43 pathology, and by inducing phosphorylation of \u03b1-synuclein at serine-129, ischaemia may also increase the risk of development of Lewy body disease. Current therapies for COVID-19 are understandably focused on supporting respiratory function, preventing thrombosis and reducing immune activation. Since angiotensin-converting enzyme (ACE)-2 is a receptor for SARS-CoV-2, and ACE inhibitors and angiotensin receptor blockers are predicted to increase ACE-2 expression, it was initially feared that their use might exacerbate COVID-19. Recent meta-analyses have instead suggested that these medications are protective. This is perhaps because SARS-CoV-2 entry may deplete ACE-2, tipping the balance towards angiotensin II-ACE-1-mediated classical RAS activation: exacerbating hypoperfusion and promoting inflammation. It may be relevant that\n                    <jats:italic>APOE<\/jats:italic>\n                    \u03b54 individuals, who seem to be at increased risk of COVID-19, also have lowest ACE-2 activity. COVID-19 is likely to leave an unexpected legacy of long-term neurological complications in a significant number of survivors. Cognitive follow-up of COVID-19 patients will be important, especially in patients who develop cerebrovascular and neurological complications during the acute illness.\n                  <\/jats:p>","DOI":"10.1186\/s13195-020-00744-w","type":"journal-article","created":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T08:03:07Z","timestamp":1609315387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":176,"title":["Cognitive impact of COVID-19: looking beyond the short term"],"prefix":"10.1186","volume":"12","author":[{"given":"Scott","family":"Miners","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick G.","family":"Kehoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8683-3625","authenticated-orcid":false,"given":"Seth","family":"Love","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,30]]},"reference":[{"key":"744_CR1","doi-asserted-by":"publisher","unstructured":"Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dub\u00e9 M, Talbot PJ. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. 2019;12(1):14. https:\/\/doi.org\/10.3390\/v12010014.","DOI":"10.3390\/v12010014"},{"issue":"6","key":"744_CR2","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.4049\/jimmunol.173.6.4030","volume":"173","author":"WG Glass","year":"2004","unstructured":"Glass WG, et al. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J Immunol. 2004;173(6):4030\u20139.","journal-title":"J Immunol"},{"issue":"3","key":"744_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1084\/jem.20050828","volume":"202","author":"J Gu","year":"2005","unstructured":"Gu J, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202(3):415\u201324.","journal-title":"J Exp Med"},{"issue":"6","key":"744_CR4","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/jmv.25728","volume":"92","author":"YC Li","year":"2020","unstructured":"Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92(6):552\u20135.","journal-title":"J Med Virol"},{"key":"744_CR5","doi-asserted-by":"publisher","unstructured":"Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767\u201383. https:\/\/doi.org\/10.1016\/S1474-4422(20)30221-0.","DOI":"10.1016\/S1474-4422(20)30221-0"},{"key":"744_CR6","doi-asserted-by":"publisher","unstructured":"Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683\u201390. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1127.","DOI":"10.1001\/jamaneurol.2020.1127"},{"issue":"23","key":"744_CR7","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1056\/NEJMc2008597","volume":"382","author":"J Helms","year":"2020","unstructured":"Helms J, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382(23):2268\u201370.","journal-title":"N Engl J Med"},{"key":"744_CR8","doi-asserted-by":"publisher","unstructured":"Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, Sultan M, Easton A, Breen G, Zandi M, Coles JP, Manji H, Al-Shahi Salman R, Menon DK, Nicholson TR, Benjamin LA, Carson A, Smith C, Turner MR, Solomon T, Kneen R, Pett SL, Galea I, Thomas RH, Michael BD. CoroNerve Study Group. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020;7(10):875\u201382. https:\/\/doi.org\/10.1016\/S2215-0366(20)30287-X.","DOI":"10.1016\/S2215-0366(20)30287-X"},{"key":"744_CR9","doi-asserted-by":"publisher","unstructured":"Lu Y, Li X, Geng D, Mei N, Wu PY, Huang CC, Jia T, Zhao Y, Wang D, Xiao A, Yin B. Cerebral micro-structural changes in COVID-19 patients - an MRI-based 3-month follow-up study. EClinicalMed, 2020;25:100484. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100484.","DOI":"10.1016\/j.eclinm.2020.100484"},{"key":"744_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3389\/fneur.2020.00308","volume":"11","author":"A Pereira","year":"2020","unstructured":"Pereira A. Long-term neurological threats of COVID-19: a call to update the thinking about the outcomes of the coronavirus pandemic. Front Neurol. 2020;11:308.","journal-title":"Front Neurol"},{"issue":"1","key":"744_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13195-020-00640-3","volume":"12","author":"MT Heneka","year":"2020","unstructured":"Heneka MT, et al. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. 2020;12(1):69.","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"744_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/ene.12443","volume":"22","author":"A Lindlau","year":"2015","unstructured":"Lindlau A, et al. Predictors of hippocampal atrophy in critically ill patients. Eur J Neurol. 2015;22(2):410\u20135.","journal-title":"Eur J Neurol"},{"issue":"16","key":"744_CR13","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1001\/jama.2010.1553","volume":"304","author":"TJ Iwashyna","year":"2010","unstructured":"Iwashyna TJ, et al. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304(16):1787\u201394.","journal-title":"JAMA"},{"issue":"6","key":"744_CR14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S1474-4422(14)70017-1","volume":"13","author":"CN Widmann","year":"2014","unstructured":"Widmann CN, Heneka MT. Long-term cerebral consequences of sepsis. Lancet Neurol. 2014;13(6):630\u20136.","journal-title":"Lancet Neurol"},{"issue":"3","key":"744_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S2213-2600(18)30062-6","volume":"6","author":"TD Girard","year":"2018","unstructured":"Girard TD, et al. Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study. Lancet Respir Med. 2018;6(3):213\u201322.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"744_CR16","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s13054-019-2626-z","volume":"23","author":"C Sasannejad","year":"2019","unstructured":"Sasannejad C, Ely EW, Lahiri S. Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms. Crit Care. 2019;23(1):352.","journal-title":"Crit Care"},{"key":"744_CR17","doi-asserted-by":"publisher","unstructured":"Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, Jayaseelan DL, Kumar G, Raftopoulos RE, Zambreanu L, Vivekanandam V, Khoo A, Geraldes R, Chinthapalli K, Boyd E, Tuzlali H, Price G, Christofi G, Morrow J, McNamara P, McLoughlin B, Lim ST, Mehta PR, Levee V, Keddie S, Yong W, Trip SA, Foulkes AJM, Hotton G, Miller TD, Everitt AD, Carswell C, Davies NWS, Yoong M, Attwell D, Sreedharan J, Silber E, Schott JM, Chandratheva A, Perry RJ, Simister R, Checkley A, Longley N, Farmer SF, Carletti F, Houlihan C, Thom M, Lunn MP, Spillane J, Howard R, Vincent A, Werring DJ, Hoskote C, J\u00e4ger HR, Manji H, Zandi MS. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020;143(10):3104\u201320. https:\/\/doi.org\/10.1093\/brain\/awaa240.","DOI":"10.1093\/brain\/awaa240"},{"key":"744_CR18","doi-asserted-by":"publisher","unstructured":"Hern\u00e1ndez-Fern\u00e1ndez F, Sandoval Valencia H, Barbella-Aponte RA, Collado-Jim\u00e9nez R, Ayo-Mart\u00edn \u00d3, Barrena C, Molina-Nuevo JD, Garc\u00eda-Garc\u00eda J, Lozano-Seti\u00e9n E, Alcahut-Rodriguez C, Mart\u00ednez-Mart\u00edn \u00c1, S\u00e1nchez-L\u00f3pez A, Segura T. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain. 2020;143(10):3089\u2013103. https:\/\/doi.org\/10.1093\/brain\/awaa239.","DOI":"10.1093\/brain\/awaa239"},{"key":"744_CR19","doi-asserted-by":"publisher","unstructured":"Benussi A, Pilotto A, Premi E, Libri I, Giunta M, Agosti C, Alberici A, Baldelli E, Benini M, Bonacina S, Brambilla L, Caratozzolo S, Cortinovis M, Costa A, Cotti Piccinelli S, Cottini E, Cristillo V, Delrio I, Filosto M, Gamba M, Gazzina S, Gilberti N, Gipponi S, Imarisio A, Invernizzi P, Leggio U, Leonardi M, Liberini P, Locatelli M, Masciocchi S, Poli L, Rao R, Risi B, Rozzini L, Scalvini A, Schiano di Cola F, Spezi R, Vergani V, Volonghi I, Zoppi N, Borroni B, Magoni M, Pezzini A, Padovani A. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy. Neurology. 2020;95(7):e910\u201320. https:\/\/doi.org\/10.1212\/WNL.0000000000009848.","DOI":"10.1212\/WNL.0000000000009848"},{"issue":"4","key":"744_CR20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/1747493020921664","volume":"15","author":"G Aggarwal","year":"2020","unstructured":"Aggarwal G, Lippi G, Michael Henry B. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): a pooled analysis of published literature. Int J Stroke. 2020;15(4):385\u20139.","journal-title":"Int J Stroke"},{"issue":"20","key":"744_CR21","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1056\/NEJMc2009787","volume":"382","author":"TJ Oxley","year":"2020","unstructured":"Oxley TJ, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020;382(20):e60.","journal-title":"N Engl J Med"},{"issue":"2","key":"744_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000508958","volume":"12","author":"ST Reddy","year":"2020","unstructured":"Reddy ST, et al. Cerebrovascular disease in patients with COVID-19: a review of the literature and case series. Case Rep Neurol. 2020;12(2):199\u2013209.","journal-title":"Case Rep Neurol"},{"issue":"7","key":"744_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","volume":"20","author":"LA Teuwen","year":"2020","unstructured":"Teuwen LA, et al. COVID-19: the vasculature unleashed. Nat Rev Immunol. 2020;20(7):389\u201391.","journal-title":"Nat Rev Immunol"},{"issue":"10234","key":"744_CR24","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417\u20138.","journal-title":"Lancet"},{"key":"744_CR25","doi-asserted-by":"publisher","unstructured":"Solomon IH, Normandin E, Bhattacharyya S, Mukerji SS, Keller K, Ali AS, Adams G, Hornick JL, Padera RF Jr, Sabeti P. Neuropathological Features of Covid-19. N Engl J Med. 2020;383(10):98\u201392. https:\/\/doi.org\/10.1056\/NEJMc2019373.","DOI":"10.1056\/NEJMc2019373"},{"key":"744_CR26","doi-asserted-by":"publisher","unstructured":"Coolen T, Lolli V, Sadeghi N, Rovai A, Trotta N, Taccone FS, Creteur J, Henrard S, Goffard JC, Dewitte O, Naeije G, Goldman S, De Ti\u00e8ge X. Early postmortem brain MRI findings in COVID-19 non-survivors. Neurology. 2020;95(14):e2016\u201327. https:\/\/doi.org\/10.1212\/WNL.0000000000010116.","DOI":"10.1212\/WNL.0000000000010116"},{"key":"744_CR27","doi-asserted-by":"publisher","unstructured":"Kanberg N, Ashton NJ, Andersson LM, Yilmaz A, Lindh M, Nilsson S, Price RW, Blennow K, Zetterberg H, Gissl\u00e9n M. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020;95(12):e1754\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000010111.","DOI":"10.1212\/WNL.0000000000010111"},{"issue":"11","key":"744_CR28","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","volume":"19","author":"J Matschke","year":"2020","unstructured":"Matschke J, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919\u201329.","journal-title":"Lancet Neurol"},{"key":"744_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijid.2020.03.062","volume":"94","author":"T Moriguchi","year":"2020","unstructured":"Moriguchi T, et al. A first case of meningitis\/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55\u20138.","journal-title":"Int J Infect Dis"},{"issue":"7","key":"744_CR30","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/jmv.25915","volume":"92","author":"A Paniz-Mondolfi","year":"2020","unstructured":"Paniz-Mondolfi A, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol. 2020;92(7):699\u2013702.","journal-title":"J Med Virol"},{"issue":"2","key":"744_CR31","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631\u20137.","journal-title":"J Pathol"},{"issue":"6","key":"744_CR32","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/cvr\/cvaa078","volume":"116","author":"L Chen","year":"2020","unstructured":"Chen L, et al. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020;116(6):1097\u2013100.","journal-title":"Cardiovasc Res"},{"issue":"7","key":"744_CR33","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","volume":"11","author":"AM Baig","year":"2020","unstructured":"Baig AM, et al. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11(7):995\u20138.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"744_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40249-020-00662-x","volume":"9","author":"MY Li","year":"2020","unstructured":"Li MY, et al. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9(1):45.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"744_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbrc.2020.03.044","volume":"526","author":"F Qi","year":"2020","unstructured":"Qi F, et al. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun. 2020;526(1):135\u201340.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"744_CR36","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","volume":"26","author":"W Sungnak","year":"2020","unstructured":"Sungnak W, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):681\u20137.","journal-title":"Nat Med"},{"key":"744_CR37","doi-asserted-by":"publisher","unstructured":"Chen R, et al. The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in human and mouse brain. BioRxiv. 2020; https:\/\/doi.org\/10.1101\/2020.04.07.030650.","DOI":"10.1101\/2020.04.07.030650"},{"key":"744_CR38","doi-asserted-by":"publisher","unstructured":"Song E, et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. BioRxiv. 2020; https:\/\/doi.org\/10.1101\/2020.06.25.169946.","DOI":"10.1101\/2020.06.25.169946"},{"key":"744_CR39","doi-asserted-by":"publisher","unstructured":"Zhang BZ, Chu H, Han S, Shuai H, Deng J, Hu YF, Gong HR, Lee AC, Zou Z, Yau T, Wu W, Hung IF, Chan JF, Yuen KY, Huang JD. SARS-CoV-2 infects human neural progenitor cells and brain organoids. Cell Res. 2020;30(10):928\u201331. https:\/\/doi.org\/10.1038\/s41422-020-0390-x.","DOI":"10.1038\/s41422-020-0390-x"},{"key":"744_CR40","doi-asserted-by":"publisher","unstructured":"Kase Y, Okano H. Expression of ACE2 and a viral virulence-regulating factor CCN family member 1 in human iPSC-derived neural cells: implications for COVID-19-related CNS disorders. Inflamm Regen. 2020;40:32. https:\/\/doi.org\/10.1186\/s41232-020-00143-6.","DOI":"10.1186\/s41232-020-00143-6"},{"key":"744_CR41","doi-asserted-by":"publisher","unstructured":"Ramani, A., et al., SARS-CoV-2 targets cortical neurons of 3D human brain organoids and shows neurodegeneration-like effects BioRxiv, 2020. doi: https:\/\/doi.org\/10.1101\/2020.05.20.106575doi.","DOI":"10.1101\/2020.05.20.106575doi"},{"issue":"1","key":"744_CR42","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13195-016-0217-7","volume":"8","author":"PG Kehoe","year":"2016","unstructured":"Kehoe PG, et al. Angiotensin-converting enzyme 2 is reduced in Alzheimer\u2019s disease in association with increasing amyloid-beta and tau pathology. Alzheimers Res Ther. 2016;8(1):50.","journal-title":"Alzheimers Res Ther"},{"key":"744_CR43","doi-asserted-by":"publisher","unstructured":"He, L., et al., Pericyte-specific vascular expression of SARS-CoV-2 receptor ACE2 \u2013 implications for microvascular inflammation and hypercoagulopathy in COVID-19 patients. prepublished bioRxiv doi: https:\/\/doi.org\/10.1101\/2020.05.11.0885002020.","DOI":"10.1101\/2020.05.11.0885002020"},{"key":"744_CR44","doi-asserted-by":"publisher","unstructured":"Wang, K., et al., SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. doi: https:\/\/doi.org\/10.1101\/2020.03.14.9883452020.","DOI":"10.1101\/2020.03.14.9883452020"},{"key":"744_CR45","doi-asserted-by":"publisher","unstructured":"Cantuti-Castelvetri L, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and provides a possible pathway into the central nervous system. BioRxix. 2020; https:\/\/doi.org\/10.1101\/2020.06.07.137802.","DOI":"10.1101\/2020.06.07.137802"},{"key":"744_CR46","doi-asserted-by":"publisher","unstructured":"Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the Nervous System. Cell. 2020;183(1):16-27.e1. https:\/\/doi.org\/10.1016\/j.cell.2020.08.028.","DOI":"10.1016\/j.cell.2020.08.028"},{"key":"744_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","volume":"107","author":"E Zenaro","year":"2017","unstructured":"Zenaro E, Piacentino G, Constantin G. The blood-brain barrier in Alzheimer\u2019s disease. Neurobiol Dis. 2017;107:41\u201356.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"744_CR48","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1177\/0271678X15610340","volume":"36","author":"D Attwell","year":"2016","unstructured":"Attwell D, et al. What is a pericyte? J Cereb Blood Flow Metab. 2016;36(2):451\u20135.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"744_CR49","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nn.4288","volume":"19","author":"MD Sweeney","year":"2016","unstructured":"Sweeney MD, Ayyadurai S, Zlokovic BV. Pericytes of the neurovascular unit: key functions and signaling pathways. Nat Neurosci. 2016;19(6):771\u201383.","journal-title":"Nat Neurosci"},{"issue":"7494","key":"744_CR50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature13165","volume":"508","author":"CN Hall","year":"2014","unstructured":"Hall CN, et al. Capillary pericytes regulate cerebral blood flow in health and disease. Nature. 2014;508(7494):55\u201360.","journal-title":"Nature"},{"issue":"7323","key":"744_CR51","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature09522","volume":"468","author":"A Armulik","year":"2010","unstructured":"Armulik A, et al. Pericytes regulate the blood-brain barrier. Nature. 2010;468(7323):557\u201361.","journal-title":"Nature"},{"issue":"3","key":"744_CR52","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1387\/ijdb.103167dr","volume":"55","author":"D Ribatti","year":"2011","unstructured":"Ribatti D, Nico B, Crivellato E. The role of pericytes in angiogenesis. Int J Dev Biol. 2011;55(3):261\u20138.","journal-title":"Int J Dev Biol"},{"issue":"5","key":"744_CR53","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","volume":"181","author":"CGK Ziegler","year":"2020","unstructured":"Ziegler CGK, et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020;181(5):1016\u201335. e19.","journal-title":"Cell"},{"key":"744_CR54","doi-asserted-by":"publisher","first-page":"180160","DOI":"10.1038\/sdata.2018.160","volume":"5","author":"L He","year":"2018","unstructured":"He L, et al. Single-cell RNA sequencing of mouse brain and lung vascular and vessel-associated cell types. Sci Data. 2018;5:180160.","journal-title":"Sci Data"},{"key":"744_CR55","doi-asserted-by":"publisher","first-page":"35108","DOI":"10.1038\/srep35108","volume":"6","author":"L He","year":"2016","unstructured":"He L, et al. Analysis of the brain mural cell transcriptome. Sci Rep. 2016;6:35108.","journal-title":"Sci Rep"},{"issue":"7693","key":"744_CR56","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nature25739","volume":"554","author":"M Vanlandewijck","year":"2018","unstructured":"Vanlandewijck M, et al. A molecular atlas of cell types and zonation in the brain vasculature. Nature. 2018;554(7693):475\u201380.","journal-title":"Nature"},{"key":"744_CR57","doi-asserted-by":"publisher","unstructured":"Cardot-Leccia N, Hubiche T, Dellamonica J, Burel-Vandenbos F, Passeron T. Pericyte alteration sheds light on micro-vasculopathy in COVID-19 infection. Intensive Care Med. 2020;46(9):1777\u20138. https:\/\/doi.org\/10.1007\/s00134-020-06147-7.","DOI":"10.1007\/s00134-020-06147-7"},{"issue":"7821","key":"744_CR58","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430\u20136.","journal-title":"Nature"},{"key":"744_CR59","doi-asserted-by":"publisher","unstructured":"Atkins JL, Masoli JAH, Delgado J, Pilling LC, Kuo CL, Kuchel GA, Melzer D. Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort. J Gerontol A Biol Sci Med Sci. 2020;75(11):2224\u201330. https:\/\/doi.org\/10.1093\/gerona\/glaa183.","DOI":"10.1093\/gerona\/glaa183"},{"key":"744_CR60","doi-asserted-by":"publisher","unstructured":"Mok VCT, Pendlebury S, Wong A, Alladi S, Au L, Bath PM, Biessels GJ, Chen C, Cordonnier C, Dichgans M, Dominguez J, Gorelick PB, Kim S, Kwok T, Greenberg SM, Jia J, Kalaria R, Kivipelto M, Naegandran K, Lam LCW, Lam BYK, Lee ATC, Markus HS, O'Brien J, Pai MC, Pantoni L, Sachdev P, Skoog I, Smith EE, Srikanth V, Suh GH, Wardlaw J, Ko H, Black SE, Scheltens P. Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID-19 pandemic, now and in the future. Alzheimers Dement. 2020;16(11):1571\u201381. https:\/\/doi.org\/10.1002\/alz.12143.","DOI":"10.1002\/alz.12143"},{"issue":"3","key":"744_CR61","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S1474-4422(18)30442-3","volume":"18","author":"ST Pendlebury","year":"2019","unstructured":"Pendlebury ST, Rothwell PM, Oxford Vascular S. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular study. Lancet Neurol. 2019;18(3):248\u201358.","journal-title":"Lancet Neurol"},{"issue":"1","key":"744_CR62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12916-017-0779-7","volume":"15","author":"MD Mijajlovic","year":"2017","unstructured":"Mijajlovic MD, et al. Post-stroke dementia - a comprehensive review. BMC Med. 2017;15(1):11.","journal-title":"BMC Med"},{"issue":"11","key":"744_CR63","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1007\/s00415-008-0944-1","volume":"255","author":"SS Staekenborg","year":"2008","unstructured":"Staekenborg SS, et al. Small vessel versus large vessel vascular dementia: risk factors and MRI findings. J Neurol. 2008;255(11):1644\u201351. discussion 1813-4.","journal-title":"J Neurol"},{"issue":"3","key":"744_CR64","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/01.STR.28.3.491","volume":"28","author":"CL Sudlow","year":"1997","unstructured":"Sudlow CL, Warlow CP. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke. 1997;28(3):491\u20139.","journal-title":"Stroke"},{"issue":"9","key":"744_CR65","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","volume":"42","author":"PB Gorelick","year":"2011","unstructured":"Gorelick PB, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2011;42(9):2672\u2013713.","journal-title":"Stroke"},{"issue":"7","key":"744_CR66","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S1474-4422(19)30079-1","volume":"18","author":"JM Wardlaw","year":"2019","unstructured":"Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18(7):684\u201396.","journal-title":"Lancet Neurol"},{"issue":"2","key":"744_CR67","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1177\/0271678X15606723","volume":"36","author":"L Ostergaard","year":"2016","unstructured":"Ostergaard L, et al. Cerebral small vessel disease: capillary pathways to stroke and cognitive decline. J Cereb Blood Flow Metab. 2016;36(2):302\u201325.","journal-title":"J Cereb Blood Flow Metab"},{"key":"744_CR68","doi-asserted-by":"publisher","unstructured":"Brun G, Hak JF, Coze S, Kaphan E, Carvelli J, Girard N, Stellmann JP. COVID-19-White matter and globus pallidum lesions: demyelination or small-vessel vasculitis? Neurol Neuroimmunol Neuroinflamm. 2020;7(4):e777. https:\/\/doi.org\/10.1212\/NXI.0000000000000777.","DOI":"10.1212\/NXI.0000000000000777"},{"issue":"1","key":"744_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-020-02166-2","volume":"140","author":"RR Reichard","year":"2020","unstructured":"Reichard RR, et al. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020;140(1):1\u20136.","journal-title":"Acta Neuropathol"},{"key":"744_CR70","doi-asserted-by":"publisher","unstructured":"Lang M, Buch K, Li MD, Mehan WA Jr, Lang AL, Leslie-Mazwi TM, Rincon SP. Leukoencephalopathy Associated with Severe COVID-19 Infection: Sequela of Hypoxemia? AJNR Am J Neuroradiol. 2020;41(9):1641\u20135. https:\/\/doi.org\/10.3174\/ajnr.A6671.","DOI":"10.3174\/ajnr.A6671"},{"key":"744_CR71","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neuroscience.2013.11.026","volume":"276","author":"IJ Bennett","year":"2014","unstructured":"Bennett IJ, Madden DJ. Disconnected aging: cerebral white matter integrity and age-related differences in cognition. Neuroscience. 2014;276:187\u2013205.","journal-title":"Neuroscience"},{"issue":"1","key":"744_CR72","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuroimage.2010.11.016","volume":"55","author":"M Ystad","year":"2011","unstructured":"Ystad M, et al. Cortico-striatal connectivity and cognition in normal aging: a combined DTI and resting state fMRI study. Neuroimage. 2011;55(1):24\u201331.","journal-title":"Neuroimage"},{"issue":"5","key":"744_CR73","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1474-4422(13)70060-7","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12(5):483\u201397.","journal-title":"Lancet Neurol"},{"issue":"3","key":"744_CR74","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nm.4482","volume":"24","author":"A Montagne","year":"2018","unstructured":"Montagne A, et al. Pericyte degeneration causes white matter dysfunction in the mouse central nervous system. Nat Med. 2018;24(3):326\u201337.","journal-title":"Nat Med"},{"issue":"5","key":"744_CR75","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.neuron.2017.10.008","volume":"96","author":"MA Petersen","year":"2017","unstructured":"Petersen MA, et al. Fibrinogen activates BMP signaling in oligodendrocyte progenitor cells and inhibits remyelination after vascular damage. Neuron. 2017;96(5):1003\u201312. e7.","journal-title":"Neuron"},{"issue":"5","key":"744_CR76","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.bbadis.2015.08.024","volume":"1862","author":"A Keable","year":"2016","unstructured":"Keable A, et al. Deposition of amyloid \u03b2 in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy. Biochim Biophys Acta. 2016;1862(5):1037\u201346.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"744_CR77","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","volume":"18","author":"RO Weller","year":"2008","unstructured":"Weller RO, et al. Perivascular drainage of amyloid-\u03b2 peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer\u2019s disease. Brain Pathol. 2008;18(2):253\u201366.","journal-title":"Brain Pathol"},{"issue":"11","key":"744_CR78","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/cvr\/cvy113","volume":"114","author":"R Brown","year":"2018","unstructured":"Brown R, et al. Understanding the role of the perivascular space in cerebral small vessel disease. Cardiovasc Res. 2018;114(11):1462\u201373.","journal-title":"Cardiovasc Res"},{"issue":"17","key":"744_CR79","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1042\/CS20160381","volume":"131","author":"H Mestre","year":"2017","unstructured":"Mestre H, et al. Perivascular spaces, glymphatic dysfunction, and small vessel disease. Clin Sci (Lond). 2017;131(17):2257\u201374.","journal-title":"Clin Sci (Lond)"},{"issue":"12","key":"744_CR80","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1212\/WNL.0000000000003746","volume":"88","author":"A Charidimou","year":"2017","unstructured":"Charidimou A, et al. MRI-visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology. 2017;88(12):1157\u201364.","journal-title":"Neurology"},{"issue":"10","key":"744_CR81","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1161\/STROKEAHA.114.005568","volume":"45","author":"A Charidimou","year":"2014","unstructured":"Charidimou A, et al. White matter perivascular spaces are related to cortical superficial siderosis in cerebral amyloid angiopathy. Stroke. 2014;45(10):2930\u20135.","journal-title":"Stroke"},{"issue":"1","key":"744_CR82","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1212\/01.wnl.0000438225.02729.04","volume":"82","author":"A Charidimou","year":"2014","unstructured":"Charidimou A, et al. White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy? Neurology. 2014;82(1):57\u201362.","journal-title":"Neurology"},{"issue":"5","key":"744_CR83","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/BF00788496","volume":"90","author":"E Czarnowska","year":"1995","unstructured":"Czarnowska E, Karwatowska-Prokopczuk E. Ultrastructural demonstration of endothelial glycocalyx disruption in the reperfused rat heart. Involvement of oxygen free radicals. Basic Res Cardiol. 1995;90(5):357\u201364.","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"744_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-4800(86)90027-4","volume":"44","author":"S Ishiharajima","year":"1986","unstructured":"Ishiharajima S, et al. Early membrane damage during ischemia in rat heart. Exp Mol Pathol. 1986;44(1):1\u20136.","journal-title":"Exp Mol Pathol"},{"key":"744_CR85","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12916-014-0206-2","volume":"12","author":"J Attems","year":"2014","unstructured":"Attems J, Jellinger KA. The overlap between vascular disease and Alzheimer's disease--lessons from pathology. BMC Med. 2014;12:206.","journal-title":"BMC Med"},{"issue":"3","key":"744_CR86","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ana.410190306","volume":"19","author":"A Brun","year":"1986","unstructured":"Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol. 1986;19(3):253\u201362.","journal-title":"Ann Neurol"},{"issue":"5","key":"744_CR87","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00401-015-1522-0","volume":"131","author":"S Love","year":"2016","unstructured":"Love S, Miners JS. Cerebrovascular disease in ageing and Alzheimer\u2019s disease. Acta Neuropathol. 2016;131(5):645\u201358.","journal-title":"Acta Neuropathol"},{"issue":"14","key":"744_CR88","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1042\/CS20170148","volume":"131","author":"S Love","year":"2017","unstructured":"Love S, Miners JS. Small vessel disease, neurovascular regulation and cognitive impairment: post-mortem studies reveal a complex relationship, still poorly understood. Clin Sci (Lond). 2017;131(14):1579\u201389.","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"744_CR89","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","volume":"85","author":"A Montagne","year":"2015","unstructured":"Montagne A, et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85(2):296\u2013302.","journal-title":"Neuron"},{"issue":"2","key":"744_CR90","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, et al. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med. 2019;25(2):270\u20136.","journal-title":"Nat Med"},{"issue":"6","key":"744_CR91","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/ana.24647","volume":"79","author":"S Lee","year":"2016","unstructured":"Lee S, et al. White matter hyperintensities are a core feature of Alzheimer\u2019s disease: evidence from the dominantly inherited Alzheimer network. Ann Neurol. 2016;79(6):929\u201339.","journal-title":"Ann Neurol"},{"issue":"5","key":"744_CR92","doi-asserted-by":"publisher","first-page":"e0195838","DOI":"10.1371\/journal.pone.0195838","volume":"13","author":"S Lee","year":"2018","unstructured":"Lee S, et al. White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer\u2019s disease. Plos One. 2018;13(5):e0195838.","journal-title":"Plos One"},{"issue":"47","key":"744_CR93","doi-asserted-by":"publisher","first-page":"E4502","DOI":"10.1073\/pnas.1317918110","volume":"110","author":"TL Benzinger","year":"2013","unstructured":"Benzinger TL, et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2013;110(47):E4502\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"744_CR94","doi-asserted-by":"publisher","unstructured":"Nortley R, Korte N, Izquierdo P, Hirunpattarasilp C, Mishra A, Jaunmuktane Z, Kyrargyri V, Pfeiffer T, Khennouf L, Madry C, Gong H, Richard-Loendt A, Huang W, Saito T, Saido TC, Brandner S, Sethi H, Attwell D. Amyloid \u03b2 oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes. Science. 2019;365(6450):eaav9518. https:\/\/doi.org\/10.1126\/science.aav9518.","DOI":"10.1126\/science.aav9518"},{"key":"744_CR95","doi-asserted-by":"publisher","unstructured":"Hald ES, Timm CD, Alford PW. Amyloid Beta Influences Vascular Smooth Muscle Contractility and Mechanoadaptation. J Biomech Eng. 2016;138(11). https:\/\/doi.org\/10.1115\/1.4034560.","DOI":"10.1115\/1.4034560"},{"issue":"3","key":"744_CR96","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.neulet.2006.03.047","volume":"401","author":"S Marco","year":"2006","unstructured":"Marco S, Skaper SD. Amyloid \u03b2-peptide1-42 alters tight junction protein distribution and expression in brain microvessel endothelial cells. Neurosci Lett. 2006;401(3):219\u201324.","journal-title":"Neurosci Lett"},{"issue":"5","key":"744_CR97","first-page":"1101","volume":"14","author":"LM Tai","year":"2010","unstructured":"Tai LM, et al. Amyloid-\u03b2-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation. J Cell Mol Med. 2010;14(5):1101\u201312.","journal-title":"J Cell Mol Med"},{"issue":"8","key":"744_CR98","doi-asserted-by":"publisher","first-page":"e23789","DOI":"10.1371\/journal.pone.0023789","volume":"6","author":"KE Biron","year":"2011","unstructured":"Biron KE, et al. Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer\u2019s disease. Plos One. 2011;6(8):e23789.","journal-title":"Plos One"},{"issue":"2","key":"744_CR99","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1161\/STROKEAHA.111.627562","volume":"43","author":"AM Hartz","year":"2012","unstructured":"Hartz AM, et al. Amyloid-\u03b2 contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke. 2012;43(2):514\u201323.","journal-title":"Stroke"},{"issue":"1","key":"744_CR100","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/jcbfm.2015.44","volume":"36","author":"MR Halliday","year":"2016","unstructured":"Halliday MR, et al. Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer\u2019s disease. J Cereb Blood Flow Metab. 2016;36(1):216\u201327.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"744_CR101","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/bpa.12004","volume":"23","author":"JD Sengillo","year":"2013","unstructured":"Sengillo JD, et al. Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer\u2019s disease. Brain Pathol. 2013;23(3):303\u201310.","journal-title":"Brain Pathol"},{"key":"744_CR102","doi-asserted-by":"publisher","unstructured":"Ding R, Hase Y, Ameen-Ali KE, Ndung'u M, Stevenson W, Barsby J, Gourlay R, Akinyemi T, Akinyemi R, Uemura MT, Polvikoski T, Mukaetova-Ladinska E, Ihara M, Kalaria RN. Loss of capillary pericytes and the blood-brain barrier in white matter in poststroke and vascular dementias and Alzheimer's disease. Brain Pathol. 2020;30(6):1087\u2013101. https:\/\/doi.org\/10.1111\/bpa.12888.","DOI":"10.1111\/bpa.12888"},{"key":"744_CR103","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1038\/ncomms3932","volume":"4","author":"AP Sagare","year":"2013","unstructured":"Sagare AP, et al. Pericyte loss influences Alzheimer-like neurodegeneration in mice. Nat Commun. 2013;4:2932.","journal-title":"Nat Commun"},{"issue":"1","key":"744_CR104","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/0271678X17690761","volume":"38","author":"JS Miners","year":"2018","unstructured":"Miners JS, Schulz I, Love S. Differing associations between A\u03b2 accumulation, hypoperfusion, blood-brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer\u2019s disease. J Cereb Blood Flow Metab. 2018;38(1):103\u201315.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"744_CR105","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1046\/j.1471-4159.1997.68031135.x","volume":"68","author":"MM Verbeek","year":"1997","unstructured":"Verbeek MM, et al. Rapid degeneration of cultured human brain pericytes by amyloid \u03b2 protein. J Neurochem. 1997;68(3):1135\u201341.","journal-title":"J Neurochem"},{"issue":"2","key":"744_CR106","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ana.25399","volume":"85","author":"JS Rabin","year":"2019","unstructured":"Rabin JS, et al. Vascular risk and \u03b2-amyloid are synergistically associated with cortical tau. Ann Neurol. 2019;85(2):272\u20139.","journal-title":"Ann Neurol"},{"issue":"8","key":"744_CR107","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/jamaneurol.2018.0975","volume":"75","author":"HJ Kim","year":"2018","unstructured":"Kim HJ, et al. Assessment of extent and role of tau in subcortical vascular cognitive impairment using 18F-AV1451 positron emission tomography imaging. JAMA Neurol. 2018;75(8):999\u20131007.","journal-title":"JAMA Neurol"},{"issue":"1\u20132","key":"744_CR108","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.brainres.2004.05.106","volume":"1022","author":"Y Wen","year":"2004","unstructured":"Wen Y, et al. Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein. Brain Res. 2004;1022(1\u20132):30\u20138.","journal-title":"Brain Res"},{"key":"744_CR109","doi-asserted-by":"publisher","first-page":"23964","DOI":"10.1038\/srep23964","volume":"6","author":"L Qiu","year":"2016","unstructured":"Qiu L, et al. Chronic cerebral hypoperfusion enhances tau hyperphosphorylation and reduces autophagy in Alzheimer's disease mice. Sci Rep. 2016;6:23964.","journal-title":"Sci Rep"},{"issue":"2","key":"744_CR110","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1006\/exnr.1998.6899","volume":"154","author":"KK Burkhart","year":"1998","unstructured":"Burkhart KK, et al. Alterations in tau phosphorylation in rat and human neocortical brain slices following hypoxia and glucose deprivation. Exp Neurol. 1998;154(2):464\u201372.","journal-title":"Exp Neurol"},{"key":"744_CR111","doi-asserted-by":"publisher","unstructured":"Liu CC, Yamazaki Y, Heckman MG, Martens YA, Jia L, Yamazaki A, Diehl NN, Zhao J, Zhao N, DeTure M, Davis MD, Felton LM, Qiao W, Li Y, Li H, Fu Y, Wang N, Wren M, Aikawa T, Holm ML, Oue H, Linares C, Allen M, Carrasquillo MM, Murray ME, Petersen RC, Ertekin-Taner N, Dickson DW, Kanekiyo T, Bu G. Tau and apolipoprotein E modulate cerebrovascular tight junction integrity independent of cerebral amyloid angiopathy in Alzheimer's disease. Alzheimers Dement. 2020;16(10):1372\u201383. https:\/\/doi.org\/10.1002\/alz.12104.","DOI":"10.1002\/alz.12104"},{"issue":"6","key":"744_CR112","doi-asserted-by":"publisher","first-page":"E1289","DOI":"10.1073\/pnas.1710329115","volume":"115","author":"RE Bennett","year":"2018","unstructured":"Bennett RE, et al. Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2018;115(6):E1289\u201398.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"744_CR113","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s41593-020-0686-7","volume":"23","author":"L Park","year":"2020","unstructured":"Park L, et al. Tau induces PSD95-neuronal NOS uncoupling and neurovascular dysfunction independent of neurodegeneration. Nat Neurosci. 2020;23(9):1079\u201389.","journal-title":"Nat Neurosci"},{"issue":"5","key":"744_CR114","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/nan.12599","volume":"46","author":"P Bourassa","year":"2020","unstructured":"Bourassa P, et al. Brain mural cell loss in the parietal cortex in Alzheimer\u2019s disease correlates with cognitive decline and TDP-43 pathology. Neuropathol Appl Neurobiol. 2020;46(5):458\u201377.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"744_CR115","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12974-018-1350-y","volume":"15","author":"SS Thammisetty","year":"2018","unstructured":"Thammisetty SS, et al. Age-related deregulation of TDP-43 after stroke enhances NF-kappaB-mediated inflammation and neuronal damage. J Neuroinflammation. 2018;15(1):312.","journal-title":"J Neuroinflammation"},{"issue":"5\u20138","key":"744_CR116","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13195-014-0077-y","volume":"6","author":"M Swirski","year":"2014","unstructured":"Swirski M, et al. Evaluating the relationship between amyloid-\u03b2 and \u03b1-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson\u2019s disease. Alzheimers Res Ther. 2014;6(5\u20138):77.","journal-title":"Alzheimers Res Ther"},{"key":"744_CR117","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fimmu.2016.00033","volume":"7","author":"E Pietronigro","year":"2016","unstructured":"Pietronigro E, Zenaro E, Constantin G. Imaging of leukocyte trafficking in Alzheimer\u2019s disease. Front Immunol. 2016;7:33.","journal-title":"Front Immunol"},{"issue":"8","key":"744_CR118","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nm.3913","volume":"21","author":"E Zenaro","year":"2015","unstructured":"Zenaro E, et al. Neutrophils promote Alzheimer\u2019s disease-like pathology and cognitive decline via LFA-1 integrin. Nat Med. 2015;21(8):880\u20136.","journal-title":"Nat Med"},{"issue":"1","key":"744_CR119","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neurobiolaging.2013.07.025","volume":"35","author":"RM McManus","year":"2014","unstructured":"McManus RM, et al. Respiratory infection promotes T cell infiltration and amyloid-\u03b2 deposition in APP\/PS1 mice. Neurobiol Aging. 2014;35(1):109\u201321.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"744_CR120","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271\u201380. e8.","journal-title":"Cell"},{"key":"744_CR121","doi-asserted-by":"publisher","unstructured":"Xu J, Lazartigues E. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus. Cell Mol Neurobiol. 2020:1\u20135. https:\/\/doi.org\/10.1007\/s10571-020-00915-1.","DOI":"10.1007\/s10571-020-00915-1"},{"key":"744_CR122","doi-asserted-by":"publisher","unstructured":"Lukiw WJ, Pogue A, Hill JM. SARS-CoV-2 Infectivity and Neurological Targets in the Brain. Cell Mol Neurobiol. 2020:1\u20138. https:\/\/doi.org\/10.1007\/s10571-020-00947-7.","DOI":"10.1007\/s10571-020-00947-7"},{"issue":"15","key":"744_CR123","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.1128\/JVI.00737-08","volume":"82","author":"J Netland","year":"2008","unstructured":"Netland J, et al. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82(15):7264\u201375.","journal-title":"J Virol"},{"key":"744_CR124","doi-asserted-by":"publisher","unstructured":"Jiang RD, Liu MQ, Chen Y, Shan C, Zhou YW, Shen XR, Li Q, Zhang L, Zhu Y, Si HR, Wang Q, Min J, Wang X, Zhang W, Li B, Zhang HJ, Baric RS, Zhou P, Yang XL, Shi ZL. Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2. Cell. 2020;182(1):50\u20138.e8. https:\/\/doi.org\/10.1016\/j.cell.2020.05.027.","DOI":"10.1016\/j.cell.2020.05.027"},{"issue":"8","key":"744_CR125","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11(8):875\u20139.","journal-title":"Nat Med"},{"issue":"2","key":"744_CR126","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1128\/JVI.01248-09","volume":"84","author":"I Glowacka","year":"2010","unstructured":"Glowacka I, et al. Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. J Virol. 2010;84(2):1198\u2013205.","journal-title":"J Virol"},{"issue":"22","key":"744_CR127","doi-asserted-by":"publisher","first-page":"7809","DOI":"10.1073\/pnas.0711241105","volume":"105","author":"S Haga","year":"2008","unstructured":"Haga S, et al. Modulation of TNF-\u03b1-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-\u03b1 production and facilitates viral entry. Proc Natl Acad Sci U S A. 2008;105(22):7809\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"744_CR128","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/HYPERTENSIONAHA.109.140145","volume":"55","author":"AJ Ferreira","year":"2010","unstructured":"Ferreira AJ, et al. Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases. Hypertension. 2010;55(2):207\u201313.","journal-title":"Hypertension"},{"issue":"2","key":"744_CR129","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","volume":"17","author":"M Paz Ocaranza","year":"2020","unstructured":"Paz Ocaranza M, et al. Counter-regulatory renin-angiotensin system in cardiovascular disease. Nat Rev Cardiol. 2020;17(2):116\u201329.","journal-title":"Nat Rev Cardiol"},{"key":"744_CR130","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13231-016-0022-1","volume":"8","author":"MM Arroja","year":"2016","unstructured":"Arroja MM, Reid E, McCabe C. Therapeutic potential of the renin angiotensin system in ischaemic stroke. Exp Transl Stroke Med. 2016;8:8.","journal-title":"Exp Transl Stroke Med"},{"issue":"6","key":"744_CR131","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1524-6175.2007.06602.x","volume":"9","author":"SG Chrysant","year":"2007","unstructured":"Chrysant SG. The pathophysiologic role of the brain renin-angiotensin system in stroke protection: clinical implications. J Clin Hypertens (Greenwich). 2007;9(6):454\u20139.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"7","key":"744_CR132","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s11906-014-0440-1","volume":"16","author":"CA McCarthy","year":"2014","unstructured":"McCarthy CA, Facey LJ, Widdop RE. The protective arms of the renin-angiontensin system in stroke. Curr Hypertens Rep. 2014;16(7):440.","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"744_CR133","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00401-019-02098-6","volume":"139","author":"CE Evans","year":"2020","unstructured":"Evans CE, et al. ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer\u2019s disease. Acta Neuropathol. 2020;139(3):485\u2013502.","journal-title":"Acta Neuropathol"},{"key":"744_CR134","doi-asserted-by":"publisher","first-page":"16024","DOI":"10.1038\/npjamd.2016.24","volume":"2","author":"XL Wang","year":"2016","unstructured":"Wang XL, et al. Deficiency of angiotensin-converting enzyme 2 causes deterioration of cognitive function. NPJ Aging Mech Dis. 2016;2:16024.","journal-title":"NPJ Aging Mech Dis"},{"issue":"11","key":"744_CR135","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1042\/CS20200492","volume":"134","author":"K Lanza","year":"2020","unstructured":"Lanza K, et al. Covid-19: the renin-angiotensin system imbalance hypothesis. Clin Sci (Lond). 2020;134(11):1259\u201364.","journal-title":"Clin Sci (Lond)"},{"key":"744_CR136","doi-asserted-by":"publisher","unstructured":"Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med. 2020;76:14\u201320. https:\/\/doi.org\/10.1016\/j.ejim.2020.04.037.","DOI":"10.1016\/j.ejim.2020.04.037"},{"issue":"6","key":"744_CR137","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.114.03743","volume":"64","author":"MR Deshotels","year":"2014","unstructured":"Deshotels MR, et al. Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism. Hypertension. 2014;64(6):1368\u201375.","journal-title":"Hypertension"},{"key":"744_CR138","doi-asserted-by":"publisher","unstructured":"Pasanen L, Launonen H, Siltari A, Korpela R, Vapaatalo H, Salmenkari H, Forsgard RA. Age-related changes in the local intestinal renin-angiotensin system in normotensive and spontaneously hypertensive rats. J Physiol Pharmacol. 2019;70(2). https:\/\/doi.org\/10.26402\/jpp.2019.2.03.","DOI":"10.26402\/jpp.2019.2.03"},{"issue":"12","key":"744_CR139","doi-asserted-by":"publisher","first-page":"e1226","DOI":"10.1097\/CCM.0000000000002008","volume":"44","author":"LR Schouten","year":"2016","unstructured":"Schouten LR, et al. Age-dependent changes in the pulmonary renin-angiotensin system are associated with severity of lung injury in a model of acute lung injury in rats. Crit Care Med. 2016;44(12):e1226\u201335.","journal-title":"Crit Care Med"},{"issue":"19","key":"744_CR140","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/j.lfs.2005.09.038","volume":"78","author":"X Xie","year":"2006","unstructured":"Xie X, et al. Age- and gender-related difference of ACE2 expression in rat lung. Life Sci. 2006;78(19):2166\u201371.","journal-title":"Life Sci"},{"key":"744_CR141","doi-asserted-by":"publisher","first-page":"6731093","DOI":"10.1155\/2016\/6731093","volume":"2016","author":"HE Yoon","year":"2016","unstructured":"Yoon HE, et al. Age-associated changes in the vascular renin-angiotensin system in mice. Oxid Med Cell Longev. 2016;2016:6731093.","journal-title":"Oxid Med Cell Longev"},{"issue":"14","key":"744_CR142","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1177\/1535370217718808","volume":"242","author":"A Bukowska","year":"2017","unstructured":"Bukowska A, et al. Protective regulation of the ACE2\/ACE gene expression by estrogen in human atrial tissue from elderly men. Exp Biol Med (Maywood). 2017;242(14):1412\u201323.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"6","key":"744_CR143","doi-asserted-by":"publisher","first-page":"L1280","DOI":"10.1152\/ajplung.00153.2020","volume":"318","author":"KE Stelzig","year":"2020","unstructured":"Stelzig KE, et al. Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2020;318(6):L1280\u20131.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"744_CR144","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41421-020-0147-1","volume":"6","author":"Y Cao","year":"2020","unstructured":"Cao Y, et al. Comparative genetic analysis of the novel coronavirus (2019-nCoV\/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov. 2020;6:11.","journal-title":"Cell Discov"},{"issue":"8","key":"744_CR145","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/sj.emboj.7600640","volume":"24","author":"W Li","year":"2005","unstructured":"Li W, et al. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 2005;24(8):1634\u201343.","journal-title":"EMBO J"},{"key":"744_CR146","doi-asserted-by":"publisher","unstructured":"Grover A, Oberoi M. A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Eur Heart J Cardiovasc Pharmacother. 2020:pvaa064. https:\/\/doi.org\/10.1093\/ehjcvp\/pvaa064.","DOI":"10.1093\/ehjcvp\/pvaa064"},{"key":"744_CR147","doi-asserted-by":"publisher","first-page":"104927","DOI":"10.1016\/j.phrs.2020.104927","volume":"158","author":"X Zhang","year":"2020","unstructured":"Zhang X, et al. ACEI\/ARB use and risk of infection or severity or mortality of COVID-19: a systematic review and meta-analysis. Pharmacol Res. 2020;158:104927.","journal-title":"Pharmacol Res"},{"key":"744_CR148","doi-asserted-by":"publisher","first-page":"101833","DOI":"10.1016\/j.pupt.2019.101833","volume":"58","author":"D Wang","year":"2019","unstructured":"Wang D, et al. Renin-angiotensin-system, a potential pharmacological candidate, in acute respiratory distress syndrome during mechanical ventilation. Pulm Pharmacol Ther. 2019;58:101833.","journal-title":"Pulm Pharmacol Ther"},{"key":"744_CR149","doi-asserted-by":"publisher","unstructured":"Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934\u201343. https:\/\/doi.org\/10.1001\/jamainternmed.2020.0994.","DOI":"10.1001\/jamainternmed.2020.0994"},{"issue":"8","key":"744_CR150","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-2600(20)30304-0","volume":"8","author":"E Fan","year":"2020","unstructured":"Fan E, et al. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? Lancet Respir Med. 2020;8(8):816\u201321.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"744_CR151","doi-asserted-by":"publisher","first-page":"R24","DOI":"10.1186\/cc8887","volume":"14","author":"KC Doerschug","year":"2010","unstructured":"Doerschug KC, et al. Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis. Crit Care. 2010;14(1):R24.","journal-title":"Crit Care"},{"issue":"7047","key":"744_CR152","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","volume":"436","author":"Y Imai","year":"2005","unstructured":"Imai Y, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112\u20136.","journal-title":"Nature"},{"issue":"9","key":"744_CR153","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1097\/PCC.0b013e3182a55735","volume":"14","author":"RM Wosten-van Asperen","year":"2013","unstructured":"Wosten-van Asperen RM, et al. Imbalance between pulmonary angiotensin-converting enzyme and angiotensin-converting enzyme 2 activity in acute respiratory distress syndrome. Pediatr Crit Care Med. 2013;14(9):e438\u201341.","journal-title":"Pediatr Crit Care Med"},{"issue":"5","key":"744_CR154","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1681\/ASN.2016101066","volume":"28","author":"SD Crowley","year":"2017","unstructured":"Crowley SD, Rudemiller NP. Immunologic effects of the renin-angiotensin system. J Am Soc Nephrol. 2017;28(5):1350\u201361.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"744_CR155","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","volume":"9","author":"J Meng","year":"2020","unstructured":"Meng J, et al. Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect. 2020;9(1):757\u201360.","journal-title":"Emerg Microbes Infect"},{"issue":"6","key":"744_CR156","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00109-012-0859-2","volume":"90","author":"GJ Rey-Parra","year":"2012","unstructured":"Rey-Parra GJ, et al. Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury. J Mol Med (Berl). 2012;90(6):637\u201347.","journal-title":"J Mol Med (Berl)"},{"issue":"12","key":"744_CR157","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/qjmed\/hcz206","volume":"112","author":"Y Fang","year":"2019","unstructured":"Fang Y, Gao F, Liu Z. Angiotensin-converting enzyme 2 attenuates inflammatory response and oxidative stress in hyperoxic lung injury by regulating NF-kappaB and Nrf2 pathways. QJM. 2019;112(12):914\u201324.","journal-title":"QJM"},{"issue":"11","key":"744_CR158","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1097\/CCM.0b013e31828a6688","volume":"41","author":"N Klein","year":"2013","unstructured":"Klein N, et al. Angiotensin-(1-7) protects from experimental acute lung injury. Crit Care Med. 2013;41(11):e334\u201343.","journal-title":"Crit Care Med"},{"issue":"3","key":"744_CR159","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0898-6568(02)00075-X","volume":"15","author":"JJ Haddad","year":"2003","unstructured":"Haddad JJ, Saade NE, Safieh-Garabedian B. Interleukin-10 and the regulation of mitogen-activated protein kinases: are these signalling modules targets for the anti-inflammatory action of this cytokine? Cell Signal. 2003;15(3):255\u201367.","journal-title":"Cell Signal"},{"issue":"11","key":"744_CR160","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/S2213-2600(20)30418-5","volume":"8","author":"A Zoufaly","year":"2020","unstructured":"Zoufaly A, et al. Human recombinant soluble ACE2 in severe COVID-19. Lancet Respir Med. 2020;8(11):1154\u20138.","journal-title":"Lancet Respir Med"},{"key":"744_CR161","doi-asserted-by":"crossref","unstructured":"Abd El-Aziz, T.M., A. Al-Sabi, and J.D. Stockand, Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID-19. Signal Transduct Target Ther, 2020. 5(1): p. 258.","DOI":"10.1038\/s41392-020-00374-6"},{"issue":"1","key":"744_CR162","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3233\/JAD-161265","volume":"58","author":"PG Kehoe","year":"2017","unstructured":"Kehoe PG, et al. Angiotensin-III is increased in Alzheimer\u2019s disease in association with amyloid-\u03b2 and tau pathology. J Alzheimers Dis. 2017;58(1):203\u201314.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"744_CR163","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1365-2990.2007.00885.x","volume":"34","author":"JS Miners","year":"2008","unstructured":"Miners JS, et al. Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer\u2019s disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy. Neuropathol Appl Neurobiol. 2008;34(2):181\u201393.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"744_CR164","first-page":"163","volume":"1","author":"S Miners","year":"2009","unstructured":"Miners S, et al. Angiotensin-converting enzyme levels and activity in Alzheimer\u2019s disease: differences in brain and CSF ACE and association with ACE1 genotypes. Am J Transl Res. 2009;1(2):163\u201377.","journal-title":"Am J Transl Res"},{"issue":"20","key":"744_CR165","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1016\/j.febslet.2012.09.004","volume":"586","author":"M Tian","year":"2012","unstructured":"Tian M, et al. Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains. FEBS Lett. 2012;586(20):3737\u201345.","journal-title":"FEBS Lett"},{"issue":"1","key":"744_CR166","doi-asserted-by":"publisher","first-page":"e16037","DOI":"10.1371\/journal.pone.0016037","volume":"6","author":"D Zhu","year":"2011","unstructured":"Zhu D, et al. Central angiotensin II stimulation promotes \u03b2 amyloid production in Sprague Dawley rats. Plos One. 2011;6(1):e16037.","journal-title":"Plos One"},{"issue":"3","key":"744_CR167","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3233\/JAD-171119","volume":"62","author":"PG Kehoe","year":"2018","unstructured":"Kehoe PG. The coming of age of the angiotensin hypothesis in Alzheimer\u2019s disease: progress toward disease prevention and treatment? J Alzheimers Dis. 2018;62(3):1443\u201366.","journal-title":"J Alzheimers Dis"},{"key":"744_CR168","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.neuroscience.2017.01.027","volume":"346","author":"JL Chen","year":"2017","unstructured":"Chen JL, et al. Angiotensin-(1-7) administration attenuates Alzheimer\u2019s disease-like neuropathology in rats with streptozotocin-induced diabetes via Mas receptor activation. Neuroscience. 2017;346:267\u201377.","journal-title":"Neuroscience"},{"issue":"10","key":"744_CR169","doi-asserted-by":"publisher","first-page":"8188","DOI":"10.1007\/s12035-018-0966-3","volume":"55","author":"AS Kamel","year":"2018","unstructured":"Kamel AS, et al. Stimulation of ACE2\/ANG(1-7)\/Mas axis by diminazene ameliorates Alzheimer\u2019s disease in the d-galactose-ovariectomized rat model: role of PI3K\/Akt pathway. Mol Neurobiol. 2018;55(10):8188\u2013202.","journal-title":"Mol Neurobiol"},{"issue":"6","key":"744_CR170","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1161\/01.RES.74.6.1141","volume":"74","author":"KK Griendling","year":"1994","unstructured":"Griendling KK, et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74(6):1141\u20138.","journal-title":"Circ Res"},{"issue":"4","key":"744_CR171","first-page":"639","volume":"52","author":"RM Touyz","year":"2000","unstructured":"Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. 2000;52(4):639\u201372.","journal-title":"Pharmacol Rev"},{"issue":"17","key":"744_CR172","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1097\/00001756-199411000-00018","volume":"5","author":"L Naveri","year":"1994","unstructured":"Naveri L, Stromberg C, Saavedra JM. Angiotensin II AT1 receptor mediated contraction of the perfused rat cerebral artery. Neuroreport. 1994;5(17):2278\u201380.","journal-title":"Neuroreport"},{"issue":"10","key":"744_CR173","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1001\/archopht.1997.01100160451011","volume":"115","author":"T Matsugi","year":"1997","unstructured":"Matsugi T, Chen Q, Anderson DR. Contractile responses of cultured bovine retinal pericytes to angiotensin II. Arch Ophthalmol. 1997;115(10):1281\u20135.","journal-title":"Arch Ophthalmol"},{"issue":"Pt 3","key":"744_CR174","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1113\/jphysiol.2004.073098","volume":"561","author":"H Kawamura","year":"2004","unstructured":"Kawamura H, et al. Effects of angiotensin II on the pericyte-containing microvasculature of the rat retina. J Physiol. 2004;561(Pt 3):671\u201383.","journal-title":"J Physiol"},{"issue":"3","key":"744_CR175","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/jcbfm.2008.158","volume":"29","author":"MA Fleegal-DeMotta","year":"2009","unstructured":"Fleegal-DeMotta MA, Doghu S, Banks WA. Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells. J Cereb Blood Flow Metab. 2009;29(3):640\u20137.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"744_CR176","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.neuroscience.2010.09.029","volume":"171","author":"M Zhang","year":"2010","unstructured":"Zhang M, et al. Angiotensin II induced cerebral microvascular inflammation and increased blood-brain barrier permeability via oxidative stress. Neuroscience. 2010;171(3):852\u20138.","journal-title":"Neuroscience"},{"issue":"6","key":"744_CR177","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cellsig.2012.02.005","volume":"24","author":"J Carbajo-Lozoya","year":"2012","unstructured":"Carbajo-Lozoya J, et al. Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium. Cell Signal. 2012;24(6):1261\u20139.","journal-title":"Cell Signal"},{"issue":"3","key":"744_CR178","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/jcbfm.2008.154","volume":"29","author":"JH Kim","year":"2009","unstructured":"Kim JH, et al. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy. J Cereb Blood Flow Metab. 2009;29(3):621\u20138.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"744_CR179","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/01.LAB.0000017372.76297.EB","volume":"82","author":"R Tamarat","year":"2002","unstructured":"Tamarat R, et al. Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab Invest. 2002;82(6):747\u201356.","journal-title":"Lab Invest"},{"issue":"10","key":"744_CR180","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1161\/01.RES.0000148637.85595.c5","volume":"95","author":"K Kazama","year":"2004","unstructured":"Kazama K, et al. Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ Res. 2004;95(10):1019\u201326.","journal-title":"Circ Res"},{"issue":"Suppl 2","key":"744_CR181","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s003950050221","volume":"93","author":"Y Nishimura","year":"1998","unstructured":"Nishimura Y, et al. The angiotensin AT1 receptor antagonist CV-11974 regulates cerebral blood flow and brain angiotensin AT1 receptor expression. Basic Res Cardiol. 1998;93(Suppl 2):63\u20138.","journal-title":"Basic Res Cardiol"},{"issue":"7","key":"744_CR182","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/00004872-199507000-00007","volume":"13","author":"T Vraamark","year":"1995","unstructured":"Vraamark T, et al. Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation. J Hypertens. 1995;13(7):755\u201361.","journal-title":"J Hypertens"},{"issue":"10","key":"744_CR183","doi-asserted-by":"publisher","first-page":"e0205276","DOI":"10.1371\/journal.pone.0205276","volume":"13","author":"AK Diem","year":"2018","unstructured":"Diem AK, et al. A control mechanism for intra-mural peri-arterial drainage via astrocytes: how neuronal activity could improve waste clearance from the brain. Plos One. 2018;13(10):e0205276.","journal-title":"Plos One"},{"issue":"8","key":"744_CR184","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"JM Tarasoff-Conway","year":"2015","unstructured":"Tarasoff-Conway JM, et al. Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol. 2015;11(8):457\u201370.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"744_CR185","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","volume":"16","author":"SM Greenberg","year":"2020","unstructured":"Greenberg SM, et al. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nat Rev Neurol. 2020;16(1):30\u201342.","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"744_CR186","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1016\/j.celrep.2019.02.050","volume":"26","author":"AS Munk","year":"2019","unstructured":"Munk AS, et al. PDGF-B is required for development of the glymphatic system. Cell Rep. 2019;26(11):2955\u201369. e3.","journal-title":"Cell Rep"},{"issue":"6","key":"744_CR187","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1007\/s00429-013-0629-0","volume":"219","author":"GA Gundersen","year":"2014","unstructured":"Gundersen GA, et al. Evidence that pericytes regulate aquaporin-4 polarization in mouse cortical astrocytes. Brain Struct Funct. 2014;219(6):2181\u20136.","journal-title":"Brain Struct Funct"},{"issue":"6","key":"744_CR188","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1167\/iovs.11-9154","volume":"53","author":"Y Qin","year":"2012","unstructured":"Qin Y, et al. Aquaporin changes during diabetic retinopathy in rats are accelerated by systemic hypertension and are linked to the renin-angiotensin system. Invest Ophthalmol Vis Sci. 2012;53(6):3047\u201353.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"744_CR189","doi-asserted-by":"publisher","first-page":"C420","DOI":"10.1152\/ajpcell.00409.2004","volume":"290","author":"PE Gallagher","year":"2006","unstructured":"Gallagher PE, et al. Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes. Am J Physiol Cell Physiol. 2006;290(2):C420\u20136.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"744_CR190","first-page":"145","volume":"2","author":"VK Ramanan","year":"2013","unstructured":"Ramanan VK, Saykin AJ. Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer\u2019s disease, Parkinson\u2019s disease, and related disorders. Am J Neurodegener Dis. 2013;2(3):145\u201375.","journal-title":"Am J Neurodegener Dis"},{"issue":"10","key":"744_CR191","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11910-013-0381-0","volume":"13","author":"G Tosto","year":"2013","unstructured":"Tosto G, Reitz C. Genome-wide association studies in Alzheimer\u2019s disease: a review. Curr Neurol Neurosci Rep. 2013;13(10):381.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"744_CR192","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00281-017-0662-9","volume":"40","author":"BP Morgan","year":"2018","unstructured":"Morgan BP. Complement in the pathogenesis of Alzheimer\u2019s disease. Semin Immunopathol. 2018;40(1):113\u201324.","journal-title":"Semin Immunopathol"},{"issue":"7434","key":"744_CR193","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature. 2013;493(7434):674\u20138.","journal-title":"Nature"},{"issue":"7784","key":"744_CR194","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;575(7784):669\u201373.","journal-title":"Nature"},{"issue":"7","key":"744_CR195","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1161\/01.RES.0000182677.89816.38","volume":"97","author":"E Shagdarsuren","year":"2005","unstructured":"Shagdarsuren E, et al. Complement activation in angiotensin II-induced organ damage. Circ Res. 2005;97(7):716\u201324.","journal-title":"Circ Res"},{"issue":"6","key":"744_CR196","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1161\/ATVBAHA.113.303120","volume":"34","author":"C Zhang","year":"2014","unstructured":"Zhang C, et al. Complement 5a receptor mediates angiotensin II-induced cardiac inflammation and remodeling. Arterioscler Thromb Vasc Biol. 2014;34(6):1240\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"744_CR197","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000488242","volume":"4","author":"M Zhao","year":"2018","unstructured":"Zhao M, et al. Angiotensin II stimulates the NLRP3 inflammasome to induce podocyte injury and mitochondrial dysfunction. Kidney Dis (Basel). 2018;4(2):83\u201394.","journal-title":"Kidney Dis (Basel)"},{"issue":"6","key":"744_CR198","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41577-020-0320-7","volume":"20","author":"AM Risitano","year":"2020","unstructured":"Risitano AM, et al. Complement as a target in COVID-19? Nat Rev Immunol. 2020;20(6):343\u20134.","journal-title":"Nat Rev Immunol"},{"key":"744_CR199","doi-asserted-by":"publisher","unstructured":"Choudhury A, Mukherjee S. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. J Med Virol. 2020;92(10):2105\u201313. https:\/\/doi.org\/10.1002\/jmv.25987.","DOI":"10.1002\/jmv.25987"},{"issue":"8","key":"744_CR200","doi-asserted-by":"publisher","first-page":"e104020","DOI":"10.1371\/journal.pone.0104020","volume":"9","author":"PR De Batista","year":"2014","unstructured":"De Batista PR, et al. Toll-like receptor 4 upregulation by angiotensin II contributes to hypertension and vascular dysfunction through reactive oxygen species production. Plos One. 2014;9(8):e104020.","journal-title":"Plos One"},{"issue":"10","key":"744_CR201","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/hr.2015.55","volume":"38","author":"T Nakashima","year":"2015","unstructured":"Nakashima T, et al. TLR4 is a critical regulator of angiotensin II-induced vascular remodeling: the roles of extracellular SOD and NADPH oxidase. Hypertens Res. 2015;38(10):649\u201355.","journal-title":"Hypertens Res"},{"issue":"1","key":"744_CR202","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/cvr\/cvu067","volume":"103","author":"RB Dange","year":"2014","unstructured":"Dange RB, et al. Central blockade of TLR4 improves cardiac function and attenuates myocardial inflammation in angiotensin II-induced hypertension. Cardiovasc Res. 2014;103(1):17\u201327.","journal-title":"Cardiovasc Res"},{"issue":"7","key":"744_CR203","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/s41556-020-0526-8","volume":"22","author":"BN Sheikh","year":"2020","unstructured":"Sheikh BN, et al. Neural metabolic imbalance induced by MOF dysfunction triggers pericyte activation and breakdown of vasculature. Nat Cell Biol. 2020;22(7):828\u201341.","journal-title":"Nat Cell Biol"},{"key":"744_CR204","doi-asserted-by":"publisher","unstructured":"Toelzer, C., et al., Unexpected free fatty acid binding pocket in the cryo-EM structure of SARS-CoV-2 spike protein. bioRxiv 2020. doi: https:\/\/doi.org\/10.1101\/2020.06.18.158584.","DOI":"10.1101\/2020.06.18.158584"},{"issue":"1","key":"744_CR205","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2020.05.032","volume":"182","author":"B Shen","year":"2020","unstructured":"Shen B, et al. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell. 2020;182(1):59\u201372. e15.","journal-title":"Cell"},{"issue":"3","key":"744_CR206","doi-asserted-by":"publisher","first-page":"e1002266","DOI":"10.1371\/journal.pmed.1002266","volume":"14","author":"SG Snowden","year":"2017","unstructured":"Snowden SG, et al. Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: a nontargeted metabolomic study. Plos Med. 2017;14(3):e1002266.","journal-title":"Plos Med"},{"key":"744_CR207","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fnagi.2017.00129","volume":"9","author":"JL Labandeira-Garcia","year":"2017","unstructured":"Labandeira-Garcia JL, et al. Brain renin-angiotensin system and microglial polarization: implications for aging and neurodegeneration. Front Aging Neurosci. 2017;9:129.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"744_CR208","doi-asserted-by":"publisher","first-page":"H404","DOI":"10.1152\/ajpheart.00247.2015","volume":"310","author":"VC Biancardi","year":"2016","unstructured":"Biancardi VC, et al. Cross talk between AT1 receptors and toll-like receptor 4 in microglia contributes to angiotensin II-derived ROS production in the hypothalamic paraventricular nucleus. Am J Physiol Heart Circ Physiol. 2016;310(3):H404\u201315.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"744_CR209","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1159\/000374047","volume":"35","author":"B Liang","year":"2015","unstructured":"Liang B, et al. Angiotensin-(1-7) attenuates angiotensin ii-induced ICAM-1, VCAM-1, and MCP-1 expression via the MAS receptor through suppression of p38 and NF-kappaB pathways in HUVECs. Cell Physiol Biochem. 2015;35(6):2472\u201382.","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"744_CR210","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.tips.2016.12.001","volume":"38","author":"J Rustenhoven","year":"2017","unstructured":"Rustenhoven J, et al. Brain pericytes as mediators of neuroinflammation. Trends Pharmacol Sci. 2017;38(3):291\u2013304.","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"744_CR211","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.mcn.2005.03.012","volume":"29","author":"K Hellner","year":"2005","unstructured":"Hellner K, et al. Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas. Mol Cell Neurosci. 2005;29(3):427\u201335.","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"744_CR212","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1042\/CS20120652","volume":"125","author":"MM Gironacci","year":"2013","unstructured":"Gironacci MM, et al. Neuromodulatory role of angiotensin-(1-7) in the central nervous system. Clin Sci (Lond). 2013;125(2):57\u201365.","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"744_CR213","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11906-014-0512-2","volume":"17","author":"DM Bennion","year":"2015","unstructured":"Bennion DM, et al. Neuroprotective mechanisms of the ACE2-angiotensin-(1-7)-Mas axis in stroke. Curr Hypertens Rep. 2015;17(2):3.","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"744_CR214","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3233\/JAD-181035","volume":"67","author":"JW Wright","year":"2019","unstructured":"Wright JW, Harding JW. Contributions by the brain renin-angiotensin system to memory, cognition, and Alzheimer's disease. J Alzheimers Dis. 2019;67(2):469\u201380.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"744_CR215","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2174\/1570159X11311020007","volume":"11","author":"T Jiang","year":"2013","unstructured":"Jiang T, et al. ACE2-Ang-(1-7)-Mas axis in brain: a potential target for prevention and treatment of ischemic stroke. Curr Neuropharmacol. 2013;11(2):209\u201317.","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"744_CR216","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1042\/CS20130324","volume":"126","author":"RW Regenhardt","year":"2014","unstructured":"Regenhardt RW, Bennion DM, Sumners C. Cerebroprotective action of angiotensin peptides in stroke. Clin Sci (Lond). 2014;126(3):195\u2013205.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"744_CR217","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3233\/JAD-150642","volume":"53","author":"K Uekawa","year":"2016","unstructured":"Uekawa K, et al. Intracerebroventricular infusion of angiotensin-(1-7) ameliorates cognitive impairment and memory dysfunction in a mouse model of Alzheimer\u2019s disease. J Alzheimers Dis. 2016;53(1):127\u201333.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"744_CR218","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3233\/JAD-181000","volume":"69","author":"C Cao","year":"2019","unstructured":"Cao C, et al. Chronic angiotensin 1-7 infusion prevents angiotensin-ii-induced cognitive dysfunction and skeletal muscle injury in a mouse model of Alzheimer\u2019s disease. J Alzheimers Dis. 2019;69(1):297\u2013309.","journal-title":"J Alzheimers Dis"},{"key":"744_CR219","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev.med.47.1.387","volume":"47","author":"AD Roses","year":"1996","unstructured":"Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer\u2019s disease. Annu Rev Med. 1996;47:387\u2013400.","journal-title":"Annu Rev Med"},{"issue":"4","key":"744_CR220","first-page":"643","volume":"54","author":"MS Tsai","year":"1994","unstructured":"Tsai MS, et al. Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet. 1994;54(4):643\u20139.","journal-title":"Am J Hum Genet"},{"issue":"7806","key":"744_CR221","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne A, et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020;581(7806):71\u20136.","journal-title":"Nature"},{"issue":"1","key":"744_CR222","first-page":"19","volume":"3","author":"S Love","year":"2014","unstructured":"Love S, et al. Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. Am J Neurodegener Dis. 2014;3(1):19\u201332.","journal-title":"Am J Neurodegener Dis"},{"key":"744_CR223","doi-asserted-by":"publisher","unstructured":"Kuo CL, Pilling LC, Atkins JL, Masoli JAH, Delgado J, Kuchel GA, Melzer D. APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort. J Gerontol A Biol Sci Med Sci. 202015;75(11):2231\u20132. https:\/\/doi.org\/10.1093\/gerona\/glaa131.","DOI":"10.1093\/gerona\/glaa131"},{"issue":"1","key":"744_CR224","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1161\/ATVBAHA.119.313169","volume":"40","author":"Y Yamazaki","year":"2020","unstructured":"Yamazaki Y, et al. ApoE (Apolipoprotein E) in brain pericytes regulates endothelial function in an isoform-dependent manner by modulating basement membrane components. Arterioscler Thromb Vasc Biol. 2020;40(1):128\u201344.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"744_CR225","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/archneurol.2009.913","volume":"67","author":"M Thambisetty","year":"2010","unstructured":"Thambisetty M, et al. APOE \u03f54 genotype and longitudinal changes in cerebral blood flow in normal aging. Arch Neurol. 2010;67(1):93\u20138.","journal-title":"Arch Neurol"},{"issue":"1","key":"744_CR226","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1038\/s41467-018-06301-2","volume":"9","author":"K Koizumi","year":"2018","unstructured":"Koizumi K, et al. Apo\u03f54 disrupts neurovascular regulation and undermines white matter integrity and cognitive function. Nat Commun. 2018;9(1):3816.","journal-title":"Nat Commun"},{"key":"744_CR227","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2020.00754","volume":"11","author":"CM Kloske","year":"2020","unstructured":"Kloske CM, Wilcock DM. The important interface between apolipoprotein E and neuroinflammation in Alzheimer\u2019s disease. Front Immunol. 2020;11:754.","journal-title":"Front Immunol"},{"key":"744_CR228","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.yjmcc.2013.11.017","volume":"66","author":"VB Patel","year":"2014","unstructured":"Patel VB, et al. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE\/ADAM-17: a positive feedback mechanism in the RAS. J Mol Cell Cardiol. 2014;66:167\u201376.","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"744_CR229","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3109\/10409231003628015","volume":"45","author":"M Gooz","year":"2010","unstructured":"Gooz M. ADAM-17: the enzyme that does it all. Crit Rev Biochem Mol Biol. 2010;45(2):146\u201369.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"6","key":"744_CR230","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/jth.14830","volume":"18","author":"S Cui","year":"2020","unstructured":"Cui S, et al. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421\u20134.","journal-title":"J Thromb Haemost"},{"key":"744_CR231","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok FA, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145\u20137.","journal-title":"Thromb Res"},{"issue":"6","key":"744_CR232","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/jth.13323","volume":"14","author":"K Martin","year":"2016","unstructured":"Martin K, et al. Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH. J Thromb Haemost. 2016;14(6):1308\u201313.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"744_CR233","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jth.14810","volume":"18","author":"J Thachil","year":"2020","unstructured":"Thachil J, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023\u20136.","journal-title":"J Thromb Haemost"},{"issue":"7","key":"744_CR234","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11886-020-01327-9","volume":"22","author":"MR Aryal","year":"2020","unstructured":"Aryal MR, et al. Venous thromboembolism in COVID-19: towards an ideal approach to thromboprophylaxis, screening, and treatment. Curr Cardiol Rep. 2020;22(7):52.","journal-title":"Curr Cardiol Rep"},{"issue":"5","key":"744_CR235","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","volume":"20","author":"X Cao","year":"2020","unstructured":"Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20(5):269\u201370.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"744_CR236","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1182\/blood.2020006964","volume":"136","author":"L Hegerova","year":"2020","unstructured":"Hegerova L, et al. Use of convalescent plasma in hospitalized patients with COVID-19: case series. Blood. 2020;136(6):759\u201362.","journal-title":"Blood"},{"issue":"1","key":"744_CR237","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/s13054-020-03215-8","volume":"24","author":"B Gucyetmez","year":"2020","unstructured":"Gucyetmez B, et al. Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study. Crit Care. 2020;24(1):492.","journal-title":"Crit Care"},{"issue":"1","key":"744_CR238","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s13054-020-03171-3","volume":"24","author":"C Morath","year":"2020","unstructured":"Morath C, et al. Plasma exchange in critically ill COVID-19 patients. Crit Care. 2020;24(1):481.","journal-title":"Crit Care"},{"key":"744_CR239","doi-asserted-by":"crossref","unstructured":"Fernandez-Ruiz M, et al. Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: a single-center cohort study. J Med Virol. 2020;.","DOI":"10.1002\/jmv.26308"},{"key":"744_CR240","doi-asserted-by":"publisher","unstructured":"Montesarchio V, Parrela R, Iommelli C, Bianco A, Manzillo E, Fraganza F, Palumbo C, Rea G, Murino P, De Rosa R, Atripaldi L, D'Abbraccio M, Curvietto M, Mallardo D, Celentano E, Grimaldi AM, Palla M, Trojaniello C, Vitale MG, Million-Weaver SL, Ascierto PA. Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy. J Immunother Cancer. 2020;8(2):e001089. https:\/\/doi.org\/10.1136\/jitc-2020-001089.","DOI":"10.1136\/jitc-2020-001089"},{"issue":"2","key":"744_CR241","doi-asserted-by":"publisher","first-page":"216","DOI":"10.14336\/AD.2020.0228","volume":"11","author":"Z Leng","year":"2020","unstructured":"Leng Z, et al. Transplantation of ACE2(\u2212) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis. 2020;11(2):216\u201328.","journal-title":"Aging Dis"},{"issue":"1","key":"744_CR242","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12974-018-1153-1","volume":"15","author":"Z Cheng","year":"2018","unstructured":"Cheng Z, et al. Mesenchymal stem cells attenuate blood-brain barrier leakage after cerebral ischemia in mice. J Neuroinflammation. 2018;15(1):135.","journal-title":"J Neuroinflammation"},{"issue":"1\u20132","key":"744_CR243","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jneuroim.2009.09.003","volume":"216","author":"YX Chao","year":"2009","unstructured":"Chao YX, He BP, Tay SS. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson\u2019s disease. J Neuroimmunol. 2009;216(1\u20132):39\u201350.","journal-title":"J Neuroimmunol"},{"issue":"12","key":"744_CR244","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1002\/stem.1808","volume":"32","author":"G Tang","year":"2014","unstructured":"Tang G, et al. Mesenchymal stem cells maintain blood-brain barrier integrity by inhibiting aquaporin-4 upregulation after cerebral ischemia. Stem Cells. 2014;32(12):3150\u201362.","journal-title":"Stem Cells"},{"issue":"10223","key":"744_CR245","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","volume":"395","author":"CD Russell","year":"2020","unstructured":"Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395(10223):473\u20135.","journal-title":"Lancet"},{"key":"744_CR246","doi-asserted-by":"publisher","unstructured":"Horby, P., et al., Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report. medRxiv, 2020. doi: https:\/\/doi.org\/10.1101\/2020.06.22.20137273..","DOI":"10.1101\/2020.06.22.20137273"},{"issue":"14","key":"744_CR247","doi-asserted-by":"publisher","first-page":"293","DOI":"10.21037\/atm.2017.07.21","volume":"5","author":"A Artigas","year":"2017","unstructured":"Artigas A, et al. Inhalation therapies in acute respiratory distress syndrome. Ann Transl Med. 2017;5(14):293.","journal-title":"Ann Transl Med"},{"issue":"4","key":"744_CR248","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1055\/s-0033-1351118","volume":"34","author":"E Ortiz-Diaz","year":"2013","unstructured":"Ortiz-Diaz E, et al. Emerging pharmacological therapies for prevention and early treatment of acute lung injury. Semin Respir Crit Care Med. 2013;34(4):448\u201358.","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"744_CR249","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.resinv.2019.12.005","volume":"58","author":"M Yamaya","year":"2020","unstructured":"Yamaya M, et al. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respir Investig. 2020;58(3):155\u201368.","journal-title":"Respir Investig"},{"key":"744_CR250","doi-asserted-by":"publisher","unstructured":"Jeon S, Ko M, Lee J, Choi I, Byun SY, Park S, Shum D, Kim S. Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs. Antimicrob Agents Chemother. 2020;64(7):e00819\u201320. https:\/\/doi.org\/10.1128\/AAC.00819-20.","DOI":"10.1128\/AAC.00819-20"},{"issue":"6504","key":"744_CR251","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj J, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369(6504):718\u201324.","journal-title":"Science"},{"key":"744_CR252","doi-asserted-by":"publisher","unstructured":"Felgenhauer U, Schoen A, Gad HH, Hartmann R, Schaubmar AR, Failing K, Drosten C, Weber F. Inhibition of SARS-CoV-2 by type I and type III interferons. J Biol Chem. 2020;295(41):13958\u201364. https:\/\/doi.org\/10.1074\/jbc.AC120.013788.","DOI":"10.1074\/jbc.AC120.013788"},{"issue":"10238","key":"744_CR253","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","volume":"395","author":"IF Hung","year":"2020","unstructured":"Hung IF, et al. Triple combination of interferon \u03b2-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020;395(10238):1695\u2013704.","journal-title":"Lancet"},{"issue":"4","key":"744_CR254","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21.","journal-title":"Lancet Respir Med"},{"key":"744_CR255","doi-asserted-by":"publisher","unstructured":"Flacco ME, Acuti Martellucci C, Bravi F, Parruti G, Cappadona R, Mascitelli A, Manfredini R, Mantovani LG, Manzoli L. Treatment with ACE inhibitors or ARBs and risk of severe\/lethal COVID-19: a meta-analysis. Heart. 2020;106(19):1519\u201324. https:\/\/doi.org\/10.1136\/heartjnl-2020-317336.","DOI":"10.1136\/heartjnl-2020-317336"},{"key":"744_CR256","doi-asserted-by":"publisher","unstructured":"Rizk JG, Kalantar-Zadeh K, Mehra MR, Lavie CJ, Rizk Y, Forthal DN. Pharmaco-Immunomodulatory Therapy in COVID-19. Drugs. 2020;80(13):1267\u201392. https:\/\/doi.org\/10.1007\/s40265-020-01367-z.","DOI":"10.1007\/s40265-020-01367-z"},{"issue":"7","key":"744_CR257","doi-asserted-by":"publisher","first-page":"102569","DOI":"10.1016\/j.autrev.2020.102569","volume":"19","author":"J Alijotas-Reig","year":"2020","unstructured":"Alijotas-Reig J, et al. Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: a comprehensive review. Autoimmun Rev. 2020;19(7):102569.","journal-title":"Autoimmun Rev"},{"key":"744_CR258","doi-asserted-by":"publisher","unstructured":"Chibber P, Haq SA, Ahmed I, Andrabi NI, Singh G. Advances in the possible treatment of COVID-19: A review. Eur J Pharmacol. 2020;883:173372. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173372.","DOI":"10.1016\/j.ejphar.2020.173372"},{"issue":"6","key":"744_CR259","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s12603-020-1389-1","volume":"24","author":"A Bianchetti","year":"2020","unstructured":"Bianchetti A, et al. Clinical presentation of COVID19 in dementia patients. J Nutr Health Aging. 2020;24(6):560\u20132.","journal-title":"J Nutr Health Aging"},{"issue":"9","key":"744_CR260","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s10072-020-04541-z","volume":"41","author":"JM Hwang","year":"2020","unstructured":"Hwang JM, et al. Neurological diseases as mortality predictive factors for patients with COVID-19: a retrospective cohort study. Neurol Sci. 2020;41(9):2317\u201324.","journal-title":"Neurol Sci"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00744-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-020-00744-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00744-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T19:35:11Z","timestamp":1670614511000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-020-00744-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":260,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["744"],"URL":"https:\/\/doi.org\/10.1186\/s13195-020-00744-w","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"5 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"170"}}